BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, June 3, 2026
Home » Topics » Medical technology

Medical technology
Medical technology RSS Feed RSS

Appointments and advancements for Oct. 31, 2023

Oct. 31, 2023
New hires and promotions in the med-tech industry, including: Danaher, Enzo Biochem, Fresenius, Opencell.
Read More

Financings for Oct. 31, 2023

Oct. 31, 2023
Med-tech firms raising money in public or private financings, including: Access Vascular, Aqtual, Neteera Technologies, Neuros Medical, Quest Diagnostics, Trinity Capital.
Read More

In the clinic for Oct. 31, 2023

Oct. 31, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Movano, Shenzhen Maiwei, Sebela, Skylinedx.
Read More

Other news to note for Oct. 31, 2023

Oct. 31, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acuitymd, Body Vision, Cardio Diagnostics, Desktop Metal, Fabric Genomics, Geminiov, Guardant, Livsmed, Lucid Diagnostics, Microbot Medical, Orthoventions, Oxford Nanopore, Pavmed.
Read More

Regulatory actions for Oct. 31, 2023

Oct. 31, 2023
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Xenix.
Read More
Zense-life cgm
Patents

Zense-Life improves methods for manufacturing its biological sensors

Oct. 30, 2023
By Simon Kerton

Zense-Life Inc. reported seeking patent protection for systems and processes for manufacturing working wires for a continuous biological sensor, that reduce cost and improve accuracy and efficiency compared to current technique.


Read More

Med-tech gainers and losers for Oct. 23-27, 2023

Oct. 30, 2023
The top 10 med-tech stock gainers and losers for the week.
Read More
MiroliverELAP - Miromatrix

United Therapeutics buying Miromatrix for up to $140M

Oct. 30, 2023
By Shani Alexander

United Therapeutics Corp. signed an agreement to acquire Miromatrix Medical Inc. for up to $140 million in cash, buying its way into additional organic growth. The deal would add Miromatrix’s comprehensive portfolio of bio-engineered organs to United’s existing organ production platform.


Read More

UK launches £100M fund to capitalize on health care AI potential

Oct. 30, 2023
By Shani Alexander
The U.K. government has launched a £100 million (US$122 million) fund that will accelerate the development of artificial intelligence (AI) tools to help tackle some of the biggest challenges in health care.
Read More
U.S. flag and White House podium

Biden administration seeks info on AI algorithms

Oct. 30, 2023
By Mark McCarty

The Biden administration has issued an executive order (EO) for artificial intelligence (AI), which addresses not only national security considerations, but public health considerations as well.


Read More
Previous 1 2 … 554 555 556 557 558 559 560 561 562 … 10249 10250 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 2, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 2, 2026
  • Pancreas 3D hologram

    ASCO 2026: A revolution in pancreatic cancer

    BioWorld
    At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
  • Healthy (left) vs. cancerous bone marrow

    BMS’ mezigdomide doubles PFS in multiple myeloma

    BioWorld
    Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
  • Antibodies attacking cancer cell

    ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal

    BioWorld
    Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing